Valuation: Axogen, Inc.

Market Cap 247.36Cr 214.16Cr 202.11Cr 183.2Cr 343.8Cr 24TCr 346.41Cr 2.41TCr 928.46Cr 12TCr 928.98Cr 908.45Cr 38TCr P/E 2026 *
-94.2x
P/E 2027 * 703x
Enterprise Value 247.36Cr 214.16Cr 202.11Cr 183.2Cr 343.8Cr 24TCr 346.41Cr 2.41TCr 928.46Cr 12TCr 928.98Cr 908.45Cr 38TCr EV / Sales 2026 *
8.85x
EV / Sales 2027 * 7.37x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day+3.84%
1 week-9.32%
Current month-13.75%
1 month-8.89%
3 months+1.81%
6 months+35.37%
Current year+33.76%
1 week 39.62
Extreme 39.62
48.1
1 month 39.62
Extreme 39.62
52.91
Current year 27.54
Extreme 27.54
52.91
1 year 15.27
Extreme 15.2701
52.91
3 years 3.45
Extreme 3.45
52.91
5 years 3.45
Extreme 3.45
52.91
10 years 3.45
Extreme 3.45
56.85
Manager TitleAgeSince
Chief Executive Officer 66 09/08/2024
Director of Finance/CFO 42 12/05/2025
Chief Operating Officer 65 10/01/2025
Director TitleAgeSince
Director/Board Member 65 01/09/2016
Director/Board Member 58 15/05/2019
Chairman 70 09/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Sell

Director

-3,500 0.0065%
11/08/26 Exercice

Director

40,059 0.0745%
10/08/26 Exercice

Compliance Officer

2,02,500 0.3767%
Change 5-day change 1-year change 3-year change Capi.($)
+3.84%-9.32%+166.79%+696.00% 247.36Cr
+0.62%-0.03%+27.98%+20.11% 23TCr
+1.55%-2.12%+6.95%-19.49% 14TCr
+2.38%+3.07%-15.95%+24.86% 13TCr
+4.82%-5.75%-56.14%-15.32% 6.23TCr
+1.99%-0.03%-18.12%-12.87% 4.94TCr
+1.36%-4.87%+10.25%+16.88% 4.86TCr
-0.09%-2.69%+19.12%+29.42% 4.14TCr
+0.41%+0.15%+38.80%+53.43% 4.01TCr
+2.16%-2.35%-17.45%+52.38% 3.12TCr
Average +1.06%-4.17%+16.22%+84.54% 7.72TCr
Weighted average by Cap. +0.54%-2.43%+4.57%+14.22%

Financials

2026 *2027 *
Net sales 28Cr 24Cr 23Cr 21Cr 39Cr 2.67TCr 39Cr 272.51Cr 104.94Cr 1.36TCr 105Cr 102.68Cr 4.31TCr 34Cr 29Cr 27Cr 25Cr 47Cr 3.21TCr 47Cr 327.18Cr 125.99Cr 1.63TCr 126.06Cr 123.28Cr 5.18TCr
Net income -2.44Cr -2.11Cr -1.99Cr -1.8Cr -3.38Cr -232.66Cr -3.41Cr -24Cr -9.14Cr -118.4Cr -9.15Cr -8.94Cr -375.78Cr 30.44L 26.35L 24.87L 22.54L 42.3L 29Cr 42.62L 2.97Cr 1.14Cr 15Cr 1.14Cr 1.12Cr 47Cr
Net Debt - -
Logo Axogen, Inc.
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Employees
622
Date Price Change Volume
14/26/14 $43.78 +3.84% 16,67,712
11/26/11 $42.16 +0.74% 34,77,622
10/26/10 $41.85 -11.47% 37,93,272
09/26/09 $47.27 +1.24% 7,28,798
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
43.78USD
Average target price
53.90USD
Spread / Average Target
+23.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AXGN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!